The aim is to address the unique health challenges faced by Armed Forces personnel and civilians living in the Himalayan belt ...
These findings provide additional insight into the Phase 3 EPICS-III results and the biochemical responses observed among ...
Fortis Hospotel Limited, a subsidiary of Fortis Healthcare Limited, is buying a 26% stake in Clean Max Sau Private Limited ...
Siemens Healthineers has appointed Preethika Sivaraj as the Deputy General Manager (DGM) of Marketing for its Point of Care ...
Dignify Therapeutics has secured U.S. Food and Drug Administration (FDA) clearance to begin human testing of an experimental ...
The trial met its primary endpoint, with both remigromig doses independently demonstrating non-inferiority to monthly ...
Eli Lilly and Company has reported new findings from a Phase 3b clinical trial suggesting a deeper biological connection between psoriasis and obesity, with combined treatment using Taltz and Zepbound ...
Lonza, a premier global contract development and manufacturing organization (CDMO), has partnered with biotechnology startup ...
We are moving from a model based mainly on observation towards one supported by imaging, measurements, biomarkers, artificial ...
An expanded partnership brings Givaudan's specialty cosmetic ingredients to Australia and New Zealand beauty manufacturers ...
Shilpa Medicare Limited, Unit 4, Jadcherla, Telangana, India was inspected by AGES, Austria from 27 July, 2026 until 30 July, ...
New industry collaboration addresses pharma's most complex development challenges and expedites patient access to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results